Introduction
============

In this study, we describe the novel overlapping phenotype of congenital cataract (CC), familial exudative vitreoretinopathy (FEVR), myopia, and primary open-angle glaucoma (POAG) segregating in an apparently autosomal-dominant fashion.

In Australia, myopia affects approximately 15% of the population \[[@r1]\], POAG affects approximately 3% of the population \[[@r2]\], CC occurs in approximately 2.2 out of every 10,000 births \[[@r3]\], and FEVR affects an estimated 7 out of every 1000,000 people (derived from comparing 13 indexed FEVR cases \[[@r4]\] to 420 CC cases \[[@r3]\]). If we were to consider these diseases as completely independent clinical entities, the highly unlikely probability of a patient having all four diseases simultaneously, or of the four diseases co-segregating, would be approximately 1 in 148 billion. This denominator is more than 20 times the total population of earth today.

Interestingly, to some extent these clinical entities can be associated with each other. Many investigators have reported the association of high myopia with cataract, glaucoma, and retinal detachment \[[@r5]\]. Other associations are less common:

1.  •anterior polar cataracts, seen in aniridia, are often associated with glaucoma \[[@r6]\];

2.  •rubella embryopathy is associated with both congenital glaucoma and CC \[[@r6]\];

3.  •aphakic glaucoma is observed very frequently, and cataract can develop as a complication of POAG-filtering surgery \[[@r6]\];

4.  •retinal detachment is a feature of Stickler syndrome and is associated often with cortical lens opacities \[[@r7]\];

5.  •retinal detachment from retinopathy of prematurity (ROP) is associated with myopia and cataract \[[@r8]\].

6.  •Retinal dystrophies are associated with myopia and posterior subcapsular cataracts \[[@r9]\].

Although researchers have identified genes associated with each of these disorders, the genetic mechanisms and their interactions still are not fully understood.

Methods
=======

We identified three closely-related index cases from three genetic-eye-disease studies: VI:7 from the Glaucoma Inheritance Study in Tasmania (GIST) \[[@r10]\], VIII:7 from the Cataract Inheritance Study in South Eastern Australia (CISSEA) \[[@r3]\], and VIII:8 from the Familial Retinal Detachment Study (FRDA) \[[@r4]\]. The GIST study had ethical approval from the Royal Hobart Hospital; the CISSEA and FRDA studies had ethical approval from the Royal Victorian Eye and Ear Hospital. In each case, the work was conducted in accordance with the tenets of the Declaration of Helsinki.

When we realized that the index cases were a grandmother and two of her grandchildren who were genetic first cousins, we decided to examine the entire pedigree in detail to characterize a potentially novel phenotype. Our ultimate aim was to identify the gene responsible for this apparently-autosomal-dominant disorder.

From the genealogy of the index cases \[[@r11]\] we identified the living members of five lineal generations, as well as surviving more-distant relatives. We invited these family members for a comprehensive ophthalmic examination \[[@r12]\], including:

1.  •a LogMAR visual acuity test,

2.  •the Goldmann applanation intraocular pressure (IOP) measurement,

3.  •refraction using a HARK-598 autorefractor (Carl Zeiss Meditec, Miami, FL),

4.  •axial length measurement using an Ocuscan^®^ (Alcon, Inc., Ft Worth, TX),

5.  •corneal pachymetry using an IOPac (Heidelberg Instruments, Heidelberg, Germany),

6.  •lens photographs,

7.  •stereoscopic optic disc photography using a Nidek 3Dx camera (Nidek, Gamagori, Japan), and

8.  •examination of the peripheral retina.

All participants provided venous blood or saliva specimens for DNA extraction and genetic analysis.

Genotyping was performed using fluorescently-tagged microsatellite markers as described previously \[[@r13]\]. Briefly, standard PCR reactions were carried out in a 25 μl volume containing 50 ng of genomic DNA using Invitrogen Taq DNA polymerase and buffers (Invitrogen). Microsatellite markers (including primer details; [Table 1](#t1){ref-type="table"}) surrounding EVR1 (D11S4187, D11S896, and D11S1367), EVR4 (D11S2006, D11S4095, and D11S937) and EVR3 (D11S929, D11S4115, D11S4154, D11S4203, D11S4083, and D11S4102) were selected from the [genome browser](http://genome.cse.ucsc.edu/index.html?org=Human&db=hg19&hgsid=202890647). Following amplification, PCR products were resolved using an ABI 3730 DNA sequencer and analyzed using GeneMapper^®^ software from the same manufacturer (Applied Biosystems, Carlsbad, CA). The coding sequence and surrounding exons of myocilin, trabecular meshwork inducible glucocorticoid response (*MYOC*) and tetraspanin 12 (*TSPAN12*; primers and conditions are listed in [Table 2](#t2){ref-type="table"}) were screened using standard direct sequencing protocols as described previously (see above) \[[@r14],[@r15]\].

###### Microsatellite primers and conditions.

  **Marker**   **Primer names and sequences (5'-3')**   **Size (bp)**   **Annealing temperature**   **Amplification conditions**
  ------------ ---------------------------------------- --------------- --------------------------- ------------------------------
  D11S4187     F TCTTGAACCCGGGAAG                       273-289         55 °C                       Invitrogen Taq & buffer
               R CTGGTGCTGTGCTTGG                                                                    
  D11S896      F ATCTCCCCTAGCTGTTTTGGA                  169-183         60 °C                       Invitrogen Taq & buffer
               R AGTTCATATCCACCTCACACA                                                               
  D11S1367     F GCTGACATTTATTCACATGGC                  224-244         60 °C                       Invitrogen Taq & buffer
               R ACAGTGTTATCTCCCTGGCA                                                                
  D11S2006     F CTTGTGGGCTGTAGTTTGCT                   \~325           55 °C                       Invitrogen Taq & buffer
               R AAAGAGTAAACTCAATGAAAGATGC                                                           
  D11S4095     F TCCCTGGCTATCTTGAATC                    173-205         55 °C                       Invitrogen Taq & buffer
               R CTTGACTGGGTCCACG                                                                    
  D11S937      F CTAATAAACAAATCCCTCTACCTCC              230-264         60 °C                       Invitrogen Taq & buffer
               R TAGTCAGTCAGGGACCCAAGT                                                               
  D11S929      F AGGCCCTTCCAAGATCAG                     218-240         60 °C                       Invitrogen Taq & buffer
               R CCCAGTTGCCGAACTACC                                                                  
  D11S4115     F TGGCATGTAAATNTAAGAGACTCAC              185-199         50 °C                       Invitrogen Taq & buffer
               R CTGCTACCTCAGAAGTATCTCAA                                                             
  D11S4154     F ATCCCTTGGCTTTCTCAGAGCAC                146-158         65 °C                       Invitrogen Taq & buffer
               R GGTGCCCCTAACCTCCATGT                                                                
  D11S4203     F GAATAGCCACTGACTTCAGG                   218-278         60 °C                       Invitrogen Taq & buffer
               R CAGGATGCTGGAATAGAGAA                                                                
  D11S4083     F TTTAACCCAAGGGCAGGAC                    178-206         55 °C                       Invitrogen Taq & buffer
               R CATGTGTACCCAAGGGCAG                                                                 
  D11S4102     F CACCACTGGGTACTGCCATC                   142-174         60 °C                       Invitrogen Taq & buffer
               R GCTAAATCCTGGAAAGCCCTG                                                               

###### *TSPAN12* primers and PCR conditions.

  **Exon**   **Primer names and sequences (5'-3')**      **Size (bp)**   **Annealing temperature**   **Amplification conditions**
  ---------- ------------------------------------------- --------------- --------------------------- ------------------------------
  2          TSPAN12-ex2-F ATGTCCCGTGTTCTCTCTCC          382             60 °C                       Invitrogen Taq & buffer
             TSPAN12-ex2-R CCAGGGGTGGATTTCTTTGT                                                       
  3          TSPAN12-ex3-F TGGTAATTGGGAAAGATATTATGTAAC   291             60 °C                       Invitrogen Taq & buffer
             TSPAN12-ex3-R CCAAAAGATCAAGGAAGAGCA                                                      
  4          TSPAN12-ex4-F TGAGGCATCATGATTGAAAGAA        346             60 °C                       Invitrogen Taq & buffer
             TSPAN12-ex4-R GCTATCACTGCTCCCTAATCTTGT                                                   
  5          TSPAN12-ex5-F GGTCCCCTTTCTTGGAGAAC          947             60 °C                       Invitrogen Taq & buffer
             TSPAN12-ex5-R TGGAAATGTGCTTTAGACACAGA                                                    
  6          TSPAN12-ex6-F GTACAAAATACCTCTTCATTTATCACA   529             60 °C                       Hot shot master mix
             TSPAN12-ex6-R GAAGAAAAGCAGGCCATGAA                                                       
  7          TSPAN12-ex7-F TGATGACAGATATAGCTCTGGGT       376             60 °C                       Hot shot master mix
             TSPAN12-ex7-R TTTTAAGGCCTTTTACATTTAGACA                                                  
  8          TSPAN12-ex8-F GCTTTCCCTGAGAACCACTG          605             60 °C                       Hot shot master mix
             TSPAN12-ex8-R CCATCCTCATTTTAAAGCATAGA                                                    

For the genotyping platform, we used Linkage Panel IVb of 6008 genome-wide single-nucleotide polymorphisms **(**SNPs; Illumina, San Diego, CA), and ran the analysis at the Center for Inherited Disease Research (CIDR) of Johns Hopkins University (Baltimore, MD). The results for the pedigree were analyzed with [Fastlink](http://www.ncbi.nlm.nih.gov/CBBresearch/Schaffer/fastlink.html) using a 2-point analysis (under a dominant model); multipoint results (both parametric and non-parametric) were analyzed using [MERLIN](http://www.genomeutwin.org/member/cores/stat/linkage/merlin.html). Merlin (Multipoint Engine for Rapid Likelihood Inference) is a software package that uses sparse inheritance trees for pedigree analysis \[[@r16]\].

Results
=======

Genealogical information was available for nine generations of the participants' family; the individuals examined for this study came from the five most recent generations.

1.  •[Figure 1](#f1){ref-type="fig"} shows the relevant portions of the full pedigree. A consanguineous loop enriched the pedigree with similar genes ([RELPAIR](http://csg.sph.umich.edu/boehnke/relpair.php) \[[@r17]\] analysis suggested a grandparent-grandchild relationship when they were actually great-grandparent and great-grandchild).Figure 1Reduced pedigree showing affected individuals. Square=male, circle=female, Top Right filled=myopia, Bottom Right filled=retinal detachment or dragged disc, Bottom Left filled=cataract, Top Left=primary open-angle glaucoma (POAG), n=examined and normal.

2.  •[Table 3](#t3){ref-type="table"} displays the participants' ophthalmic phenotypes with autorefraction sphere and cylinder, Keratometry readings, and axial length.Table 3Clinical features of family members examined.**Refractive error (D)Keratometry (D)Axial Length (mm)IDSexAge at initial examination (years)RightLeftRightLeftRightLeftCataractGlaucomaDragged disc or retinal detachment**V:2F81−0.75/-2.0x70+0.75/-1.5x6545.3/44.343.8/42.925.0523.56YesYesNoneV:4F83−2/-3.25x45−3.25/-1.0x9549.2/53.9\*48.6/46.225.4424.37YesYesDragged discVI:7F65+0.25/-3.0x180−0.25/-3.5x7545.3/42.25\*45.8/43.023.7523.88YesYesDragged discVI:12F76NRNRNRNRNRNRYesYesNoneVI:13F86NRNRNRNRNRNRNoYesNoneVII:1M450/-0.25x1800/-0.25x180NRNRNRNRNoNoNoneVII:3F430/-1.5x1800/-0.25x16040.0/43.143.4/44.3NRNRYesNoNoneVII:5M39−3.25/-4.0x180−0.5/-1x17543.5/45.143.5/43.624.6022.63YesYesDragged discVII:6F33−0.75−0.5/-0.75x170NRNRNRNRNoNoNoneVII:7M36−2.25/-0.5x155−6.25/-1.5x14542.1/ 42.343.5/43.124.6226.77YesYesDragged discVII:8F38NRNRNRNRNRNRNoNoNoneVIII:3F25−0.25/-0.5x88+0.5/-0.25x102NRNRNRNRYesNoNoneVIII:5M16−1.75/-1.25x50−6.25/-6.75x17540.0/43.143.4/ 44.3NRNRYesNoNoneVIII:6M12−2.0/-5.0x90+0.5/-0.5x160NRNRNRNRYesNoNoneVIII:7M8−5.75/-0.5x55−9.25/-3.5x9541.0/41.840.0/41.025.65NRYesNoDragged discVIII:8F17+0.5/-7.25x165NDNRNDNRNDNDNDTotal detachment OUVIII:9F15−0.25/-0.5x1350/-0.25x55NRNRNRNRNoNoNoneIX:1M31.50/-0.5x12145.3/44.343.8/42.925.05NRYesNoNoneAbbreviations: F, female; M, male; D, diopters; NR, not recorded; ND, not determinable; OU, both eyes. \*measured following cataract surgery

3.  •[Figure 2](#f2){ref-type="fig"} and [Figure 3A-N](#f3){ref-type="fig"} show photos of the optic disc, retina, and lens.Figure 2Lens, optic disc, and retina photos of individuals. In the figure, **A** indicates individual V:2; **B** indicates individual V:4; **C** indicates individual VI:7; **D** indicates individual VII:3; **E** indicates individual VII:5; **F** indicates individual VII:7; **G** indicates individual VIII:3; **H** indicates individual VIII:5; **I** indicates individual VIII:6; **J** indicates individual VIII:7; **K** indicates individual VIII:7 followup lens photo five years after first photos; **L** indicates individual VIII:8; **M** indicates individual VIII:9; and **N** indicates individual IX:1. Figure 324--2 Humphrey Visual Fields of Individuals. **A** indicates individual V:2; **B** indicates individual V:4; **C** indicates individual VI:7; **D** indicates individual VII:5; and **E** indicates individual VII:7.

4.  •[Figure 4A-E](#f4){ref-type="fig"} show visual field defects.Figure 4Haplotype analysis of FEVR genes. Only a subset of the pedigree is displayed; shaded individuals are those whose phenotype suggests FEVR. *EVR2* (Norrin) is excluded by the pedigree structure showing male to male transmission. For each locus examined, the affected individuals do not share the same haplotype, indicating that the causative gene does not reside in this region of the chromosomal. **A**: EVR1 (*FZD4*); **B**: EVR3 11p13-p12; **C**: EVR4 (*LRP5*).

Excluding the married-in spouses, we examined eight female and six male family members aged 3--86 years who apparently were affected.

1.  •Visual acuity ranged from 6/5 to perception of light.

2.  •Spherical-equivalent refractive error in Diopters (D) ranged from +0.25 D to −11.0 D, with five individuals having myopia in at least one eye of \<-3D.

3.  •Astigmatism varied from 0 to −7.25 D with the rule or −5 D against the rule.

4.  •Axial length varied from 23.75 mm to 26.77 mm.

5.  •Keratometry readings in eyes that had not been operated on ranged from 40.0 D to 48.62 D, with the largest corneal astigmatism measuring only 3.12 D.

6.  •Maximum recorded IOP ranged from 13 mmHg to 36 mmHg.

7.  •Central corneal thickness ranged from 510 μm to 590 μm.

8.  •One male (VIII:6) was found to have a distance exotropia of 25 D.

9.  •Twelve individuals (6 male and 6 female) had CC, thought to be pediatric in onset. (V:2, V:4,VI:7, VI:12, VII:3, VII:5, VII:3, VII:7, VIII:3, VIII:5, VIII:6, VIII:7, IX:1). The youngest age of documented cataract was 3 years of age (IX:1).

10. •One member (VIII:7) had photographic evidence of cataract progression ([Figure 3J,K](#f3){ref-type="fig"}). In addition, iris atrophy was noted at the 3 and 9 o'clock positions. This atrophy possibly became more notable with age ([Figure 3K](#f3){ref-type="fig"}).

11. •One female individual (VIII:8) had severe spontaneous retinal detachment consistent with FEVR, while five individuals (3 male and 2 female) had dragged retinal vessels (V:4,VI:7, VII:5, VII:7, VIII:7).

12. •Seven individuals (5 female and 2 male) had been diagnosed with POAG (V:2, V:4, VI:7, VI:12, VI:13, VII:5, VII:7).

Cataract extraction was performed on VII:7 after the cortical wedge progressed to complete lenticular opacification in the left eye and vision declined from 6/18 to 6/60. Post-operatively, this member's best-corrected visual acuity improved to 6/6. Refraction in the left eye changed from −6.25/-1.5x145 to +0.00/-0.50 X 98 following cataract surgery. The brother of this individual (VII:5) had similar surgery for cataract and astigmatism, but his visual acuity did not improve from 6/60.

Systemic associations
---------------------

None of the family members had dysmorphia or an unusual stature consistent with the facial or body habitus features of Stickler syndrome. One member, who had not worn ear protection in his industrial employment, had noise-related hearing loss (VII:7) and one (V:4) had age-related hearing loss. Only one member (V:4) was found to have a single café-au-lait spot.

One participant (VII:7) had previously been diagnosed with pulmonary alveolar proteinosis (PAP) and treated with repeated pulmonary lavage. PAP is a rare disorder related to the receptor pathway of the granulocyte macrophage--colony stimulating factor (GM-CSF); it was diagnosed after recurrent bouts of pneumonia in adult life. No other family member has experienced similar medical problems; no individual reported any renal problems.

*MYOC* screening of the index case revealed no mutation \[[@r14]\]. Haplotype analysis of a central portion of the pedigree excluded the *EVR1* frizzled family receptor 4 (*FZD4*) and *EVR4* low density lipoprotein receptor-related protein 5 (*LRP5*) *FEVR* genes (Figure 4). Unfortunately, the *EVR3* locus could be only partially excluded due to uninformative markers. Given that this gene had not been identified, we cannot exclude this locus fully. Direct screening of VIII:8 excluded the recently-identified FEVR gene *TSPAN12*.

The family was included in the International High Myopia Consortium linkage analysis \[[@r16]\]; however, the family was dropped from the multipoint analyses for chromosomes 3, 4, 6, 7, 8, 11, and 12 due to the pedigree's complexity. [Table 4](#t4){ref-type="table"} displays the two-point linkage results for this family showing the highest scoring logarithm of odds (LOD) scores above 1.5. There were multiple chromosomal SNPs of interest, but no statistically significant focal localization.

###### Summary of the Johns Hopkins Center for Inherited Disease Research (CIDR) results for the family.

  **Chromosome**   **Marker**     **Position (cM)**   **2PT-parametric (Fastlink)**   **MPT-non-parametric**   **MPT-parametric**
  ---------------- -------------- ------------------- ------------------------------- ------------------------ --------------------
  1                rs1981193      121.82              *1.863*                         NS                       NS
  1                rs1806753      160.34              *1.079*                         NS                       NS
  2                rs2053372      47.98               *1.592*                         NS                       NS
  2                rs2008535      54.9                *1.128*                         NS                       NS
  2                rs764464       65.31               *1.328*                         NS                       NS
  2                rs1022298      117.27              *1.162*                         NS                       NS
  2                rs264963       117.39              *1.162*                         NS                       NS
  3                rs2076993      46.5                *1.166*                         NS                       NS
  3                rs1348979      49.44               *1.166*                         NS                       NS
  3                rs1127732      59.51               *1.097*                         NS                       NS
  3                rs713144       60.4                *1.477*                         NS                       NS
  3                rs1382554      60.41               *1.097*                         NS                       NS
  3                rs1405793      64.61               *1.159*                         NS                       NS
  3                rs1495704      65.68               *1.159*                         NS                       NS
  3                rs1995137      66.29               *1.159*                         NS                       NS
  3                rs1351631      67.73               *1.522*                         NS                       NS
  3                rs737516       67.73               *1.522*                         NS                       NS
  3                rs1013758      67.81               *1.522*                         NS                       NS
  3                rs844438       78.91               *1.123*                         NS                       NS
  3                rs1447971      82.11               *1.842*                         NS                       NS
  3                rs935734       92.98               *1.586*                         NS                       NS
  3                rs1019374      95                  *1.069*                         NS                       NS
  3                rs1388276      99.96               *1.116*                         NS                       NS
  4                rs751266       67.19               *1.054*                         NS                       NS
  4                rs896656       93.96               *1.326*                         NS                       NS
  8                rs2203837      23.58               *1.615*                         NS                       NS
  8                rs334206       32.33               *1.241*                         NS                       NS
  8                rs241202       48.58               *1.849*                         NS                       NS
  8                rs4107736      50.87               *1.248*                         NS                       NS
  8                rs1481747      53.13               *1.103*                         NS                       NS
  8                rs1955185      61.16               *1.05*                          NS                       NS
  8                rs716583       65.56               *1.116*                         NS                       NS
  8                rs344278       74.88               *1.582*                         NS                       NS
  8                rs1460239      112.26              *1.618*                         NS                       NS
  8                rs1433396      122.14              *1.119*                         NS                       NS
  8                rs766811       138.68              *1.16*                          NS                       NS
  9                rs1532310      0.124137            *1.522*                         NS                       NS
  9                rs1532309      0.124434            *1.522*                         NS                       NS
  9                rs1143025      30.9                *1.176*                         NS                       NS
  9                rs1029015      35.12               *1.767*                         NS                       NS
  9                rs716933       60.37               *1.089*                         NS                       NS
  9                rs987187       60.4                *1.128*                         NS                       NS
  9                rs1333342      69.96               *1.477*                         NS                       NS
  10               rs1346300      75.86               *1.522*                         NS                       NS
  11               rs676943       125.79              *1.015*                         NS                       NS
  12               rs871880       58.31               *1.123*                         NS                       NS
  12               rs7134835      161.7               *1.2*                           NS                       NS
  12               rs1278602      171.56              *1.089*                         NS                       NS
  12               rs1278601      171.57              *1.089*                         NS                       NS
  12               rs937538       171.78              *1.094*                         NS                       NS
  13               rs2985981      49.25               *1.004*                         NS                       NS
  13               rs2031836      115.73              *1.003*                         NS                       NS
  15               rs1435735      46.31               *1.199*                         NS                       NS
  15               rs890153       46.31               *1.554*                         NS                       NS
  15               rs725463       60.22               *1.043*                         NS                       NS
  15               rs1445020      71.05               *1.049*                         NS                       NS
  16               rs1019141      19.98               *1.49*                          NS                       NS
  16               rs889593       122.83              0.018                           *0.701998*               1.0217
  16               rs299956       123.93              0.734                           *0.943619*               1.5971
  16               rs2076962      125.29              −0.036                          *1.127055*               1.8771
  16               rs3794668      126.97              −0.011                          *1.126755*               1.8763
  16               rs1056707      128.94              0.057                           *1.12803*                1.8782
  16               rs750740       129.03              0.399                           *1.128125*               1.8783
  16               rs463701       130.14              −0.067                          *1.129806*               1.8804
  16               rs452176       130.21              0.01                            *1.129825*               1.8804
  16               rs1006547      130.48              0.018                           *1.129924*               1.8805
  16               rs1800330      130.5               0.891                           NS                       NS
  **16**           **rs870856**   **130.83**          ***1.781***                     ***1.126244***           **1.8762**
  16               rs8577         130.86              0.549                           *1.125715*               1.8755
  17               rs721429       95.95               *1.199*                         NS                       NS
  18               rs1972602      45.77               *1.123*                         NS                       NS
  18               rs1548755      51.57               *1.252*                         NS                       NS
  18               rs1131709      56.82               *1.339*                         NS                       NS
  18               rs650680       58.25               *1.767*                         NS                       NS
  18               rs931078       84.57               *1.11*                          NS                       NS
  20               rs1535382      14.16               *1.046*                         NS                       NS
  21               rs1041756      33.98               *1.07*                          NS                       NS
  21               rs2839576      62.26               *1.324*                         NS                       NS

2-point analyses with Fastlink under a dominant model; multipoint results, both parametric and non-parametric, using the multipoint engine for rapid likelihood inference ([MERLIN](http://www.genomeutwin.org/member/cores/stat/linkage/merlin.html)). Results in italics highlight suggestive loci, while the results in bold were found to be suggestive under all models tested. Abbreviations: Chr, chromosome; cM, centimorgan; 2PT, two point; MPT, multi-point; NS, not significant.

Discussion
==========

This Australian pedigree has a unique constellation of ophthalmic features that do not appear to have been described previously. Although we were unable to identify a similar family reported in the literature, the subtle and relatively common clinical features could be overlooked.

Many investigators have reported the association of high myopia with ocular morbidities of early-onset cataract, glaucoma and retinal detachment \[[@r5]\]. Pedigrees with myopia are common, but pedigrees with so many members affected with these early ocular issues along with myopic development are extremely rare; we were not able to identify any in the published literature.

Although we cannot discount that the associated ocular features may be secondary in origin, this family raises the possibility that the same gene may be responsible for all forms of the pathology observed in the pedigree.

Retinal detachment is an uncommon disorder in young people and is most commonly identified in patients with FEVR. X-linked FEVR and Norrie disease arose from mutations in Norrin (excluded by male-to-male transmission, in this pedigree). Dominant FEVR is due to mutations in *FZD4* and *LRP5,* and has been linked to the *EVR3* locus \[[@r18]\]. We excluded these loci through linkage analysis. The recently-described gene *TSPAN12* (*EVR5*) was excluded by sequence analysis. Nonetheless, despite a well characterized FEVR mutation, there still can be considerable variation in the expressivity of the phenotype and incomplete penetrance \[[@r15],[@r18],[@r19]\] (Personal communication; T.L. Edwards, Centre for Eye Research Australia, Melbourne, Australia \[article in press\]).

Since the cataract is the most "easily characterized" phenotype in this family's pedigree, we compared it with other cataract phenotypes described in the literature. Although CC has been linked to or associated with many cataract loci and many chromosomal deletions, the causative mutation has not been identified for the majority of CC and pediatric cataract cases \[[@r6]\].

The peripheral cortical lamella wedge seen in this family is similar to that observed in Stickler syndrome \[[@r7]\] and also with neurofibromatosis Type 2 (NF2) \[[@r20]\]. Interestingly, one case describes NF2 associated with posterior subcapsular cataract and dragged disc \[[@r21]\]. In a series of 15 other NF2 patients, 12 patients had an epiretinal membrane in the macular or paramacular area and 11 patients had central posterior cortical, subcapsular, or peripheral cortical lens opacities \[[@r22]\]. NF2 arises from mutations in the *Merlin* gene on chromosome 22q12.2 \[[@r23]\].

The one case of PAP \[[@r24]\] prompted an investigation of possible genes involved in the GM-CSF pathway using the Online Mendelian Inheritance in Man^®^ ([OMIM](http://www.ncbi.nlm.nih.gov/omim)) database at Johns Hopkins University. Of three loci associated with PAP, one gene located at chromosome 22q12.2-q13.1, Granulocyte-macrophage Colony-stimulating factor receptor, beta (*CSF2RB*) is adjacent to *Merlin*. Notably, on reviewing myopia loci, the myopia linkage found by Stambolian and colleagues \[[@r25]\] for marker D22S685 lies in chromosome region 22q12. This region has also been replicated in the Beaver Dam Eye study \[[@r26]\].

The refractive error recorded in this pedigree is atypical; most hereditary myopia is symmetric and usually is not associated with high astigmatism. To date there has been little investigation of the genetics of astigmatism, though genetic factors are likely to play a role \[[@r27]\]. It would appear that the myopia in this family originates in increased axial length rather than in the more usual primary lenticular fault. The degree of astigmatism in severely affected members, however, appeared to be both lenticular and corneal, suggesting a common mechanism of growth or compensation. The causative interaction of the cataract and the increased myopia remains to be elucidated, but may involve visual form deprivation \[[@r28]\].

We hope that characterization of this unusual phenotypic constellation will identify other families with similar characteristics. Further characterization of the genes involved in this family using methods such as next-generation sequencing should help shed light on the genetics of the four clinical entities ---POAG, CC, FEVR, and myopia--- as well as their interactions. In time, this further work also may help clarify the molecular pathways of developing myopia involving retinal signaling, lens growth and axial length.
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